AMA backs off call for end to DTC pharmaceutical ads
The AMA is signaling it will not call for an end to the practice of marketing drugs directly to consumers, at its annual conference later this month in Chicago. Two resolutions drafted at last year's conference asked AMA members to back a complete ban on DTC ads, but while an AMA report to be delivered at the 2006 conference calls for many modifications in current DTC advertising practices, it does not call for an outright ban.
Advertising Age (tiered subscription model)
| 6/5
This story published in FDLI SmartBrief on 06/06/2006
Get stories like these delivered daily for FREE:
|
FDLI SmartBrief
Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more |
|